Respiratory syncytial virus infection cases in congenital heart disease patients
暂无分享,去创建一个
Soo-jin Kim | W. Shim | S. Jang | S. Kim | J. Y. Lee | J. Song | E. Choi | Soo-Jin Kim
[1] K. Henrickson,et al. Diagnostic Assays for Respiratory Syncytial Virus Disease , 2007, The Pediatric infectious disease journal.
[2] D. Noyola,et al. Impact of respiratory syncytial virus on hospital admissions in children younger than 3 years of age. , 2007, The Journal of infection.
[3] A. Leventhal,et al. Elimination of Hepatitis A Infection Outbreaks in Day Care and School Settings in Southern Israel After Introduction of the National Universal Toddler Hepatitis A Immunization Program , 2007, The Pediatric infectious disease journal.
[4] A. Bruu,et al. Respiratory syncytial virus infections in congenital heart defects--hospitalizations and costs. , 2006, Acta paediatrica.
[5] D. Fixler,et al. Respiratory syncytial virus infection in children with congenital heart disease: A review , 1996, Pediatric Cardiology.
[6] W. Mahle,et al. Economic Analysis of Palivizumab in Infants With Congenital Heart Disease , 2004, Pediatrics.
[7] D. Noyola,et al. Viral etiology of lower respiratory tract infections in hospitalized children in Mexico , 2004, The Pediatric infectious disease journal.
[8] M. Rennels,et al. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. , 2003, Pediatrics.
[9] R. Welliver. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. , 2003, The Journal of pediatrics.
[10] K.,et al. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. , 2003, The Journal of pediatrics.
[11] J. Towbin,et al. Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. , 2003, Journal of the American College of Cardiology.
[12] B. Paes. Current strategies in the prevention of respiratory syncytial virus disease. , 2003, Paediatric respiratory reviews.
[13] H. Meissner. Selected populations at increased risk from respiratory syncytial virus infection , 2003, The Pediatric infectious disease journal.
[14] P. Piedra. Clinical experience with respiratory syncytial virus vaccines , 2003, The Pediatric infectious disease journal.
[15] R. A. Blackwood,et al. Case report of Staphylococcus aureus endocarditis after navel piercing. , 2003, The Pediatric infectious disease journal.
[16] H. Jafri. Role of chemokines in respiratory syncytial virus disease. , 2002, The Pediatric infectious disease journal.
[17] T. Braciale,et al. RSV-induced immunopathology: dynamic interplay between the virus and host immune response. , 2002, Virology.
[18] P. Openshaw,et al. Immunopathogenesis of vaccine-enhanced RSV disease. , 2001, Vaccine.
[19] J. Mills,et al. Preventive and therapeutic strategies for respiratory syncytial virus infection. , 2001, Current opinion in pharmacology.
[20] M. Pérez-Ruiz,et al. Rapid Detection of Respiratory Viruses by Shell Vial Assay Using Simultaneous Culture of HEp-2, LLC-MK2, and MDCK Cells in a Single Vial , 1999, Journal of Clinical Microbiology.
[21] L. Wright,et al. Prevention of Respiratory Syncytial Virus Infections: Indications for the Use of Palivizumab and Update on the Use of RSV-IGIV , 1998, Pediatrics.
[22] E. Simões,et al. Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease , 1998 .
[23] L. Wright,et al. Respiratory syncytial virus immune globulin intravenous: Indications for use , 1997 .
[24] K. Kawazoe,et al. Cardiopulmonary bypass and cellular immunity: changes in lymphocyte subsets and natural killer cell activity. , 1993, The Annals of thoracic surgery.
[25] D. Mulder,et al. Effect of cardiopulmonary bypass on circulating lymphocyte function. , 1992, The Annals of thoracic surgery.
[26] R. Davey,et al. Changes in lymphocyte subpopulations as a result of cardiopulmonary bypass. The effect of blood transfusion. , 1991, The Journal of thoracic and cardiovascular surgery.
[27] Henry Nider,et al. Report of the Committee on Infectious Diseases , 1989 .
[28] C. Hall,et al. Respiratory syncytial viral infection in infants with congenital heart disease. , 1982, The New England journal of medicine.
[29] R. Chanock,et al. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. , 1969, American journal of epidemiology.
[30] E. H. Lennette,et al. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. , 1969, American journal of epidemiology.